Legislative record

HB 1340STATE · HawaiiIntroduced

RELATING TO MENTAL HEALTH.

Requires the Director of Health to establish a Temporary Breakthrough Therapy Designation Advisory Council within 3 months of certain breakthrough therapy designation approvals by the United States Food and Drug Administration. (SD2)

Voted 3/25/2024

Roll-call record

How representatives voted

27 yea·1 nay·3 other

Docket history

Action history

  1. 3/25/2024Received notice of discharge of all conferees (Hse. Com. No. 457).
  2. 3/22/2024House Conferee(s) discharged.
  3. 3/20/2024Received notice of all Senate conferees being discharged (Sen. Com. No. 340).
  4. 3/20/2024Senate Conferee(s) discharged.
  5. 12/11/2023Carried over to 2024 Regular Session.
  6. 4/27/2023Conference Committee Meeting will reconvene on Friday 04-28-23 2:30PM in conference room 329.
  7. 4/25/2023Conference Committee Meeting will reconvene on Thursday 04-27-23 2:30PM in conference room 329.
  8. 4/24/2023Bill scheduled for Conference Committee Meeting on Tuesday, 04-25-23 3:30PM in conference room 329.
  9. 4/24/2023Received notice of appointment of House conferees (Hse. Com. No. 839).
  10. 4/21/2023House Conferees Appointed: Belatti, Nakashima, Kitagawa Co-Chairs; Garcia.